PKM and gestational diabetes: Pharmacological agents that stabilize the tetrameric form of PKM2, thereby promoting glycolytic flux, could potentially counteract the energy deficit observed in GDM placentas, although such interventions would require a careful consideration of PKM2’s pleiotropic effects on cell proliferation and gene expression [45].